Intralesional interferon excels for challenging basal cell carcinomas

WAIKOLOA, HAWAII – Intralesional injection of interferon alfa-2b is an excellent option for the treatment of large problematic basal cell carcinomas in patients who aren’t interested in the higher-morbidity options, Dr. David L. Swanson said at the Hawaii Dermatology Seminar provided by Global...
Source: Skin and Allergy News - Category: Dermatology Source Type: news